LT3137093T - Alzheimerio ligos (ad) gydymas ir prevencija - Google Patents
Alzheimerio ligos (ad) gydymas ir prevencijaInfo
- Publication number
- LT3137093T LT3137093T LTEP15720059.3T LT15720059T LT3137093T LT 3137093 T LT3137093 T LT 3137093T LT 15720059 T LT15720059 T LT 15720059T LT 3137093 T LT3137093 T LT 3137093T
- Authority
- LT
- Lithuania
- Prior art keywords
- alzheimer
- disease
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14166354 | 2014-04-29 | ||
| EP14166355 | 2014-04-29 | ||
| PCT/EP2015/059339 WO2015165966A1 (en) | 2014-04-29 | 2015-04-29 | Treatment and prevention of alzheimer's disease (ad) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3137093T true LT3137093T (lt) | 2017-12-11 |
Family
ID=53039896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP15720059.3T LT3137093T (lt) | 2014-04-29 | 2015-04-29 | Alzheimerio ligos (ad) gydymas ir prevencija |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10478454B2 (lt) |
| EP (2) | EP3269376B1 (lt) |
| JP (1) | JP6692755B2 (lt) |
| KR (1) | KR102388363B1 (lt) |
| CN (1) | CN106659738B (lt) |
| AU (1) | AU2015254663B2 (lt) |
| CA (1) | CA2946928C (lt) |
| CY (1) | CY1119674T1 (lt) |
| DK (1) | DK3137093T3 (lt) |
| ES (2) | ES2824763T3 (lt) |
| HR (1) | HRP20171896T1 (lt) |
| HU (1) | HUE037501T2 (lt) |
| LT (1) | LT3137093T (lt) |
| NO (1) | NO3137093T3 (lt) |
| PL (1) | PL3137093T3 (lt) |
| PT (1) | PT3137093T (lt) |
| SI (1) | SI3137093T1 (lt) |
| WO (1) | WO2015165966A1 (lt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3137094B1 (en) | 2014-04-29 | 2022-12-07 | ADvantage Therapeutics, Inc. | Treatment and prevention of alzheimer's disease (ad) |
| CN106535924A (zh) | 2014-04-29 | 2017-03-22 | 阿费里斯股份公司 | 阿尔茨海默病(ad)的治疗和预防 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994016327A1 (en) | 1993-01-14 | 1994-07-21 | Pollard Harvey B | Methods and compositions for blocking amyloid protein ion channels |
| EA002526B1 (ru) * | 1997-08-21 | 2002-06-27 | П.Н.Геролиматос С.А. | Применение фанхинона для лечения болезни альцгеймера |
| TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| MX2012011340A (es) * | 2010-03-29 | 2012-11-16 | Novartis Ag | Composicion que comprende el peptido amiloide beta 1-6acoplado a una particula similar a virus y un auxiliar. |
-
2015
- 2015-04-29 NO NO15720059A patent/NO3137093T3/no unknown
- 2015-04-29 CA CA2946928A patent/CA2946928C/en active Active
- 2015-04-29 JP JP2016565267A patent/JP6692755B2/ja active Active
- 2015-04-29 ES ES17189527T patent/ES2824763T3/es active Active
- 2015-04-29 EP EP17189527.9A patent/EP3269376B1/en active Active
- 2015-04-29 PL PL15720059T patent/PL3137093T3/pl unknown
- 2015-04-29 EP EP15720059.3A patent/EP3137093B1/en active Active
- 2015-04-29 PT PT157200593T patent/PT3137093T/pt unknown
- 2015-04-29 WO PCT/EP2015/059339 patent/WO2015165966A1/en active Application Filing
- 2015-04-29 LT LTEP15720059.3T patent/LT3137093T/lt unknown
- 2015-04-29 KR KR1020167033332A patent/KR102388363B1/ko active IP Right Grant
- 2015-04-29 US US15/307,082 patent/US10478454B2/en active Active
- 2015-04-29 CN CN201580029861.5A patent/CN106659738B/zh active Active
- 2015-04-29 HU HUE15720059A patent/HUE037501T2/hu unknown
- 2015-04-29 SI SI201530145T patent/SI3137093T1/en unknown
- 2015-04-29 DK DK15720059.3T patent/DK3137093T3/en active
- 2015-04-29 ES ES15720059.3T patent/ES2651537T3/es active Active
- 2015-04-29 AU AU2015254663A patent/AU2015254663B2/en active Active
-
2017
- 2017-12-06 HR HRP20171896TT patent/HRP20171896T1/hr unknown
- 2017-12-13 CY CY20171101303T patent/CY1119674T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20171896T1 (hr) | 2018-02-23 |
| EP3137093A1 (en) | 2017-03-08 |
| CN106659738B (zh) | 2021-02-09 |
| PT3137093T (pt) | 2017-12-19 |
| EP3137093B1 (en) | 2017-09-13 |
| SI3137093T1 (en) | 2018-01-31 |
| AU2015254663B2 (en) | 2020-04-02 |
| ES2824763T3 (es) | 2021-05-13 |
| EP3269376B1 (en) | 2020-07-15 |
| AU2015254663A1 (en) | 2016-11-10 |
| EP3269376A1 (en) | 2018-01-17 |
| CA2946928C (en) | 2023-01-31 |
| CA2946928A1 (en) | 2015-11-05 |
| CY1119674T1 (el) | 2018-04-04 |
| JP6692755B2 (ja) | 2020-05-13 |
| HUE037501T2 (hu) | 2018-08-28 |
| WO2015165966A1 (en) | 2015-11-05 |
| JP2017518275A (ja) | 2017-07-06 |
| CN106659738A (zh) | 2017-05-10 |
| US20170049812A1 (en) | 2017-02-23 |
| DK3137093T3 (en) | 2017-12-11 |
| PL3137093T3 (pl) | 2018-06-29 |
| ES2651537T3 (es) | 2018-01-29 |
| US10478454B2 (en) | 2019-11-19 |
| NO3137093T3 (lt) | 2018-02-10 |
| KR20160145822A (ko) | 2016-12-20 |
| KR102388363B1 (ko) | 2022-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252839A0 (en) | Treatment of boils | |
| PT3212233T (pt) | Terapia combinada para o tratamento de doenças | |
| EP3142707A4 (en) | Methods and compositions for prevention or treatment of a disease | |
| IL247085B (en) | Methods for treating Alzheimer's disease | |
| ZA201605341B (en) | Methods of treating alzheimer's disease | |
| EP3104776A4 (en) | Diagnosis and treatment of respiratory disorders | |
| HK1251265A1 (zh) | 感染性疾病的診斷與治療 | |
| PT3151814T (pt) | Tratamento de uma lesão da pele | |
| GB201408387D0 (en) | Treatment of respiratory disorders | |
| GB201413530D0 (en) | Treatment and prevention of malaria | |
| PL3183003T3 (pl) | SPOSOBY ZAPOBIEGANIA l/LUB LECZENIA ZAKAŻENIA | |
| SG11201605745VA (en) | Targeting clptm1l for treatment and prevention of cancer | |
| IL248935A0 (en) | Diagnostic testing and treatment/prevention of Alzheimer's disease | |
| PL3137097T3 (pl) | Leczenie i profilaktyka choroby Alzheimera (AD) | |
| HK1246271A1 (zh) | 用於合成羥基-三甘油酯的方法及其用於預防和治療疾病的用途 | |
| LT3137093T (lt) | Alzheimerio ligos (ad) gydymas ir prevencija | |
| PL3137094T3 (pl) | Leczenie i profilaktyka choroby alzheimera (ad) | |
| GB201411616D0 (en) | Diagnosis and treatment of neurodegenerative disorders | |
| GB201412010D0 (en) | Treatment of hypertransaminasemia | |
| GB201622116D0 (en) | Treatment of liver disease | |
| GB201621398D0 (en) | Treatment of emt-associated disease | |
| GB201610906D0 (en) | Treatment of cardiovascular disease | |
| GB201504413D0 (en) | Treatment of disease | |
| SG11201705889VA (en) | Prevention or Treatment of Uratic or Gouty Diseases | |
| GB201511453D0 (en) | Treatment of alzheimer's disease |